IVC and iliac thrombus in the setting of IVC filter and metastatic breast cancer with brain mets. AngioDynamics, Inc. #AlphaVac was able to clear both acute and chronic thrombus and relieve lower extremity swelling. @xraytatum Tom Weinkam Joseph Bernstein @CajunBuckeye1

Looking forward to meeting attendees to share the latest on our thrombus management and atherectomy platforms! Will we see YOU there?

An impressive amount of unwanted material in the heart of this young man with NICM and HIV admitted for 3 ICD shocks. Now s/p percutaneous removal of huge RA mass with combination AngioDynamics, Inc. Angiovac and Inari Medical T24. Path pending! Osman Ahmed Sandeep Nathan, MD, MSc

Rohan Kalathiya, MD John Blair UChicagoHVC Anthony Kanelidis, MD Linda Lee, MD Parker Ward Eric Secemsky MD MSc Akhilesh Sista The PERT Consortium® Kush Desai Yevgeniy Brailovsky DO MSc FACC DR MICHAEL R JAFF Venkat Tummala MD Thomas Tu MD Shon Chakrabarti MD MPH John Moriarty Josie Beck Minhaj S Khaja, MD, MBA

OhioHealth @RiversideHosp Thank you to Michael Jolly, Joe Campbell, Dr Chris Huff, @midohiovascular and Tom Weinkam!

.Beaumont Health Dearborn had their first #Barostim implant for #heartfailure - we're honored to support Dr. Mazen Bazzi, Mahir Elder, MD, FACC, SCAI and team on their first case! #OutsmartTheHeart #cardiology #healthcare #medtech #innovation

Very interesting JACC Journals #JACCHF article on ⬇️ baroreflex sensitivity in #heartfailure! #Barostim has been shown to ⬆️ baroreflex sensitivity in patients with HFrEF, ⬇️ sympathetic and ⬆️ parasympathetic tone and improve symptoms of heart failure beyond GDMT alone.

We're honored to support AHN on their first #Barostim implant! Thanks to Drs. Satish Muluk and Matthew Lander and team on providing a new #heartfailure therapy option for their patients. #OutsmartTheHeart #cardiology #healthcare #medtech #innovation

Please stop by to say hello to me today at TCT!

Outsmaht the haht! Great last day in Boston at our first Cardiovascular Research Foundation #TCT2022 meeting. Visit booth #345 to learn more about #Barostim - an implantable device that increases baroreflex sensitivity, improving the symptoms of #heartfailure beyond #GDMT alone. #outsmarttheheart

Thank you Nadim Yared for the great demo and conversation at the @CVRx_Inc booth during #TCT2022

We're having a wonderful time at #HFSA2022 this weekend! Stop by and chat with our team to learn how rebalancing the autonomic nervous system with #Barostim improves symptoms of #heartfailure. ISI: barost.im/3AxPCsr #OutsmartTheHeart #cardiology #cardiotwitter #medtech

An elegant demonstration of baroreflex activation leading to decreased sympathetic nerve activity. Important implications in treating heart failure. #hfsa2022

Where Barostim (baroreflex activation therapy) can fit into devices we offer for management of heart failure with reduced ejection fraction (HFrEF). #hfsa2022

It was wonderful to support Drs. Thomas Charles, Ayotunde Bamimore and Georges Chahoud and team SSM Health St. Joseph Hospital on their first #Barostim implant! #OutsmartTheHeart #heartfailure #cardiology #cardiotwitter #epeeps #healthcare #medtech #innovation

We’re proud to partner with Drs. Peter Rossi and Nunzio gaglianello and team Froedtert Hospital on the first two #Barostim implants in Milwaukee! #OutsmartTheHeart #cardiology #cardiotwitter #heartfailure #healthcare #medtech #innovation

Allegheny General Hospital, part of AHN, implanted the 1st commercial #Barostim in Pittsburgh last month. Learn how #Barostim will help AHN expand care options for their patients with systolic #heartfailure. ISI: barost.im/3TnRHxk Learn more: lnkd.in/gtZbe-nq

Today we announced our 3rd quarter #FinancialResults and provided a business update. In Q3, we: 💲Nearly doubled U.S. #HeartFailure revenue ❤Launched new #Barostim Programmer ⬆Increased worldwide revenue 82% 🏥Added 20 implanting centers Learn more ➡ barost.im/3fwZEl8

Come visit me today!

We are supporting CME-accredited medical education developed by ReachMD & Medtelligence. The 1st program is “Direct from the Heart Failure Clinic: Novel Device Therapy for HFrEF Patients” w/Dr. Marat Fudim of Duke University. Access the content here: barost.im/cmenov22